Breadcrumb AMCP.org Resource Center Topics Biosimilars AMCP Submits Letter to Alaska House Finance Committee Regarding Senate Bill 32 and the Regulation of Biologic Product Substitutions Tweet this pagePost this page on FacebookPost this page on LinkedInEmail this pagePrint this page 2/27/18 AMCP Submits Letter to Alaska House Finance Committee Regarding Senate Bill 32 and the Regulation of Biologic Product Substitutions AMCP Submits Letter to Alaska House Finance Committee regarding Senate Bill 32 and the regulation of Biologic Product Substitutions.pdf Tags: Biosimilars (52) Formulary Management (12) Legislation & Regulation (17) Managed Care Practice Issues (17) Tweet this pagePost this page on FacebookPost this page on LinkedInEmail this pagePrint this page